CD274 and prostate carcinoma: pRB has been implicated in the control of PD-L1 via NF-kB in prostate cancer cells, whereby Ser249/Thr252-phosphorylated pRB binds and sequesters NF-kB (p65), preventing it from transcriptionally activating CD274 [28].